IntegraGen SA (ALINT):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:IntegraGen SA (ALINT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C2816
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
IntegraGen SA (IntegraGen) is a developer and commercializer of molecular diagnostic tests for the treatment of autism and oncology. The company provides advanced genomic and bioinformatic services, including clinical research, basic and human genetic research, bioinformatics and bioanalysis, agrigenomics, and genomics news, genomic research tools and solutions to microbiologic researchers. It also offers DNA extraction, management samples, study design, strategy, selection markers, tagging, biostatistics analysis and bioinformatics analysis of sequence data services, among others. IntegraGen develops miR-31-3p, a microRNA biomarker for metastatic colorectal and lung cancer. The company offers services in the fields of pharmacogenetics, cytogenetics, epigenetics and agriculture. It caters to patients, clinicians and researchers. The company has operations in France and the US. IntegraGen is headquartered in Paris, France.

IntegraGen SA (ALINT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
IntegraGen SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IntegraGen SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
IntegraGen SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IntegraGen SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
IntegraGen SA, Medical Devices Deals, 2012 to YTD 2018 9
IntegraGen SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
IntegraGen SA, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
AP-HP Enters into Research Agreement with IntegraGen 11
IntegraGen Enters into Agreement with Klinikum der Ludwig-Maximilians-Universitat Munchen 12
IntegraGen Enters into Agreement with Hopital Europeen Georges Pompidou 13
Licensing Agreements 14
IntegraGen Enters into Licensing Agreement with Inserm 14
Equity Offering 15
IntegraGen Raises USD4 Million in Private Placement of Shares 15
IntegraGen Completes Private Placement Of Shares For US$2.5 Million 16
IntegraGen SA – Key Competitors 17
IntegraGen SA – Key Employees 18
IntegraGen SA – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Jul 09, 2018: IntegraGen Reports 17% Revenue Growth During First Half of 2018 20
Apr 13, 2018: IntegraGen Reports 2017 Annual Results 21
Jan 09, 2018: IntegraGen Reports 2017 revenue and cash position 23
Sep 29, 2017: IntegraGen Reports Financial Results for 1st Half of 2017 24
Jul 11, 2017: Integragen Reports Continued Growth During 1st Half Of 2017 26
Apr 21, 2017: IntegraGen Announces 2016 Annual Results: Increase in operating revenues and significant improvement in operating income (+22%) 27
Jan 09, 2017: IntegraGen Reports Sharp Increase in Sales During 2016 30
Legal and Regulatory 31
Apr 23, 2018: IntegraGen Achieves ISO 13485:2016 Certification for the Design, Manufacturing and Distribution of In Vitro Diagnostic Kits 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
IntegraGen SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
IntegraGen SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IntegraGen SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
IntegraGen SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IntegraGen SA, Deals By Therapy Area, 2012 to YTD 2018 8
IntegraGen SA, Medical Devices Deals, 2012 to YTD 2018 9
IntegraGen SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AP-HP Enters into Research Agreement with IntegraGen 11
IntegraGen Enters into Agreement with Klinikum der Ludwig-Maximilians-Universitat Munchen 12
IntegraGen Enters into Agreement with Hopital Europeen Georges Pompidou 13
IntegraGen Enters into Licensing Agreement with Inserm 14
IntegraGen Raises USD4 Million in Private Placement of Shares 15
IntegraGen Completes Private Placement Of Shares For US$2.5 Million 16
IntegraGen SA, Key Competitors 17
IntegraGen SA, Key Employees 18
IntegraGen SA, Subsidiaries 19

List of Figures
IntegraGen SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
IntegraGen SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
IntegraGen SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
IntegraGen SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
IntegraGen SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
IntegraGen SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
IntegraGen SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
IntegraGen SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[IntegraGen SA (ALINT):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Copenhagen Airports AS:企業の戦略・SWOT・財務情報
    Copenhagen Airports AS - Strategy, SWOT and Corporate Finance Report Summary Copenhagen Airports AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Attica Bank S.A.
    Attica Bank S.A. - Strategy, SWOT and Corporate Finance Report Summary Attica Bank S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • University of Oxford-製薬・医療分野:企業M&A・提携分析
    Summary University of Oxford (UO) is a research and educational university that offers student training, academic research and graduation programs. The university offers graduation courses in the various fields such as humanities, mathematical, physical and life sciences; medical sciences, and conti …
  • InspireMD Inc (NSPR):医療機器:M&Aディール及び事業提携情報
    Summary InspireMD Inc (InspireMD) is a medical device company that develops and commercializes embolic prevention systems and neurovascular devices. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for us …
  • Genting Malaysia Berhad:企業の戦略・SWOT・財務情報
    Genting Malaysia Berhad - Strategy, SWOT and Corporate Finance Report Summary Genting Malaysia Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Poudre Valley Rural Electric Association, Inc.:発電所・企業SWOT分析
    Poudre Valley Rural Electric Association, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, i …
  • Whitehaven Coal Ltd:企業のM&A・事業提携・投資動向
    Whitehaven Coal Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Whitehaven Coal Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Cellumed Co Ltd (049180)-医療機器分野:企業M&A・提携分析
    Summary Cellumed Co Ltd (Cellumed), formerly Korea Bone Bank Inc, is a biotechnology company that develops bone graft substitution based on human tissue graft. The company’s portfolio encompasses spinal fixation systems; joint replacement and navigation system; bone powder; DBM gel; bio-clearant, an …
  • African Development Bank Group:企業の戦略的SWOT分析
    African Development Bank Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Groupe Galeries Lafayette:戦略・SWOT・企業財務分析
    Groupe Galeries Lafayette - Strategy, SWOT and Corporate Finance Report Summary Groupe Galeries Lafayette - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Sompo Holdings, Inc. (8630):企業の財務・戦略的SWOT分析
    Sompo Holdings, Inc. (8630) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Olin Corp (OLN):企業の財務・戦略的SWOT分析
    Olin Corp (OLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Cypress Semiconductor Corporation (CY):企業の財務・戦略的SWOT分析
    Cypress Semiconductor Corporation (CY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • U.S. National Geospatial-Intelligence Agency:企業の戦略的SWOT分析
    U.S. National Geospatial-Intelligence Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • EMCOR Group, Inc.:企業の戦略・SWOT・財務情報
    EMCOR Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary EMCOR Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Specialised Therapeutics Australia Pty Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Specialised Therapeutics Australia Pty Ltd (STA) is a biopharmaceutical company that develops and commercializes medicines in various therapeutic areas. The company’s products include abraxane, gliolan, oncotype dx, iclusig, oncotype dx prostate and aloxi. Its pipeline products comprise anam …
  • Hertz Global Holdings Inc:企業の戦略・SWOT・財務情報
    Hertz Global Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Hertz Global Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Vivergo Fuels Ltd:企業の戦略的SWOT分析
    Vivergo Fuels Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • SP Transmission plc:企業の戦略的SWOT分析
    SP Transmission plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Marina Biotech Inc (MRNA):製薬・医療:M&Aディール及び事業提携情報
    Summary Marina Biotech Inc (Marina) is a nucleic acid-based drug discovery and development company that focuses on rare diseases. It focuses on treating the intersection of arthritis, hypertension, pain, and cancer using combination therapies of already approved drugs. The company is developing and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆